Non‐eosinophilic asthma in nonsteroidal anti‐inflammatory drug exacerbated respiratory disease
Open Access
- 13 March 2023
- journal article
- research article
- Published by Wiley in Clinical and Translational Allergy
- Vol. 13 (3) , e12235
Abstract
Background: The cellular inflammatory pattern of nonsteroidal anti‐inflammatory drug–exacerbated respiratory disease (N‐ERD) is heterogeneous. However, data on the heterogeneity of non‐eosinophilic asthma (NEA) with aspirin hypersensitivity are scanty. By examination of N‐ERD patients based on clinical data and eicosanoid biomarkers we aimed to identify NEA endotypes potentially guiding clinical management.Methods: Induced sputum was collected from patients with N‐ERD. Sixty six patients (49.6% of 133 N‐ERD) with NEA were included in the hierarchical cluster analysis based on clinical and laboratory data. The quality of clustering was evaluated using internal cluster validation with different indices and a practical decision tree was proposed to simplify stratification of patients.Results: The most frequent NEA pattern was paucigranulocytic (PGA; 75.8%), remaining was neutrophilic asthma (NA; 24.2%). Four clusters were identified. Cluster #3 included the highest number of NEA patients (37.9%) with severe asthma and PGA pattern (96.0%). Cluster #1 (24.2%) included severe only asthma, with a higher prevalence of NA (50%). Cluster #2 (25.8%) comprised well‐controlled mild or severe asthma (PGA; 76.5%). Cluster #4 contained only 12.1% patients with well‐controlled moderate asthma (PGA; 62.5%). Sputum prostaglandin D2 levels distinguished cluster #1 from the remaining clusters with an area under the curve of 0.94.Conclusions: Among identified four NEA subtypes, clusters #3 and #1 represented N‐ERD patients with severe asthma but a different inflammatory signatures. All the clusters were discriminated by sputum PGD2 levels, asthma severity, and age of patients. The heterogeneity of non‐eosinophilic N‐ERD suggests a need for novel targeted interventions.Keywords
All Related Versions
Funding Information
- Narodowe Centrum Nauki (UMO‐2015/19/B/NZ5/00096, UMO‐2018/31/B/NZ5/0080)
This publication has 37 references indexed in Scilit:
- Induced sputum supernatant bioactive lipid mediators can identify subtypes of asthmaClinical & Experimental Allergy, 2015
- Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2015
- Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory diseaseJournal of Allergy and Clinical Immunology, 2013
- Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytesBlood, 2012
- A Large Subgroup of Mild-to-Moderate Asthma Is Persistently NoneosinophilicAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Optimization of phenylacetic acid derivatives for balanced CRTH2 and DP dual antagonistsBioorganic & Medicinal Chemistry Letters, 2012
- Heterogeneity of Bronchitis in Airway Diseases in Tertiary Care Clinical PracticeCanadian Respiratory Journal, 2011
- T-helper Type 2–driven Inflammation Defines Major Subphenotypes of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Inflammatory subtypes in asthma: Assessment and identification using induced sputumRespirology, 2006
- Standardised methodology of sputum induction and processingEuropean Respiratory Journal, 2002